- Conditions
- ADHD
- Interventions
- Medication as usual, STAR
- Other
- Lead sponsor
- Florida International University
- Other
- Eligibility
- 12 Years to 16 Years
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Miami, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 813
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Child Disruptive Behavior Disorders, Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder
- Interventions
- Triple P Online System, Placebo Comparator
- Other · Behavioral
- Lead sponsor
- Oregon Research Institute
- Other
- Eligibility
- 3 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 2
- States / cities
- Eugene, Oregon • Seattle, Washington
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- ATMX
- Drug
- Lead sponsor
- University of Arizona
- Other
- Eligibility
- 3 Years to 5 Years
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2004
- U.S. locations
- 1
- States / cities
- Tucson, Arizona
- Conditions
- Smoking, Withdrawal Nicotine, ADHD
- Interventions
- Cigarette smoking, Abstinence
- Behavioral
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2016
- U.S. locations
- 1
- States / cities
- Santa Ana, California
- Conditions
- Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation
- Interventions
- Omega-3 Fatty Acid, ADHD Medication
- Dietary Supplement · Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- OROS methylphenidate, Placebo
- Drug
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Atomoxetine hydrochloride, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 30 Years
- Enrollment
- 445 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 27
- States / cities
- Los Angeles, California • Rolling Hills Est., California • Spring Valley, California + 24 more
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR)
- Interventions
- ADHD Medication, Omega-3 Fatty Acids
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Preference and Goal Instrument
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Disorder With Hyperactivity
- Interventions
- Quotient®, Usual Clinic ADHD Care
- Device · Behavioral
- Lead sponsor
- Kaiser Permanente
- Other
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 207 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 3
- States / cities
- Folsom, California • Roseville, California • Walnut Creek, California
- Conditions
- Health Literacy, Attention Deficit Disorder With Hyperactivity, Computer Literacy, Information Management, Parents
- Interventions
- Use of paper forms to write down information, Computer
- Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 194 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2014
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- ADHD
- Interventions
- Methylphenidate Transdermal System
- Drug
- Lead sponsor
- Noven Therapeutics
- Industry
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 163 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 32
- States / cities
- Scottsdale, Arizona • Lafayette, California • Wildomar, California + 29 more
- Conditions
- ADHD
- Interventions
- Modafinil
- Drug
- Lead sponsor
- Cephalon
- Industry
- Eligibility
- 6 Years to 17 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 39
- States / cities
- Scottsdale, Arizona • Irvine, California • Northridge, California + 35 more
- Conditions
- Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder
- Interventions
- Centanafadine SR
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 662 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Culver City, California
- Conditions
- Attention-Deficit/Hyperactivity Disorder
- Interventions
- TAK-137, TAK-137 Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Marlton, New York
- Conditions
- ADHD
- Interventions
- NRCT-101-SR, Placebo
- Drug
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 223 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 9
- States / cities
- Garden Grove, California • Lakeland, Florida • Maitland, Florida + 6 more
- Conditions
- ADHD
- Interventions
- Magnetic Resonance Imaging (MRI), PHNO, calcitriol, Placebo oral capsule, high-resolution research tomography, Dextro Amphetamine
- Procedure · Drug · Dietary Supplement
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2023
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- ADHD - Attention Deficit Disorder With Hyperactivity, ADHD
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- 6 Years to 9 Years
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder
- Interventions
- MIP Protocol
- Behavioral
- Lead sponsor
- The National Center on Addiction and Substance Abuse at Columbia University
- Other
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- ADHD, Smoking
- Interventions
- Osmotic-Release Methylphenidate, Placebo
- Drug
- Lead sponsor
- University of Cincinnati
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 255 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 6
- States / cities
- Cambridge, Massachusetts • Rochester, Minnesota • New York, New York + 2 more
- Conditions
- Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder, Working Memory
- Interventions
- Transcranial Magnetic Stimulation (TMS), High controllability TMS target
- Device · Procedure
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years to 28 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- ADHD, Substance Abuse
- Interventions
- Methylphenidate (OROS-MPH), Methylphenidate (OROS-MPH) - Placebo
- Drug
- Lead sponsor
- University of Cincinnati
- Other
- Eligibility
- 13 Years to 18 Years
- Enrollment
- 303 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 12
- States / cities
- Denver, Colorado • Jacksonville, Florida • St. Petersburg, Florida + 9 more
- Conditions
- ADHD
- Interventions
- fMRI Neurofeedback attention task
- Combination Product
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 12 Years to 35 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Brookline, Massachusetts
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- Lisdexamfetamine Dimesylate 40 MG, Placebo
- Drug
- Lead sponsor
- Gregory Fabiano
- Other
- Eligibility
- 16 Years to 25 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Buffalo, New York